Lv1
100 积分 2025-09-10 加入
Armored chimeric antigen receptor T-cell therapy targets antigen-heterogeneous glioma
4个月前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
5个月前
已完结
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma
6个月前
已完结
Integrated chronic in vivo and in vitro screens uncover NFIL3 as a driver of T cell dysfunction
7个月前
已完结
LRRC15-CAR T cells for the treatment of osteosarcoma
8个月前
已完结
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells
8个月前
已完结
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
9个月前
已关闭
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
9个月前
已完结
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
9个月前
已关闭
In Vivo Generation and Manipulation of CAR-T-mimicking Cells via Magnetic Bispecific Nano-antibody for Solid Tumor Therapy
9个月前
已完结
皖公网安备34019202002308
